Synopsis
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
56
PharmaCompass offers a list of Noscapine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Noscapine manufacturer or Noscapine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Noscapine manufacturer or Noscapine supplier.
PharmaCompass also assists you with knowing the Noscapine API Price utilized in the formulation of products. Noscapine API Price is not always fixed or binding as the Noscapine Price is obtained through a variety of data sources. The Noscapine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Noscapin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Noscapin, including repackagers and relabelers. The FDA regulates Noscapin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Noscapin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Noscapin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Noscapin supplier is an individual or a company that provides Noscapin active pharmaceutical ingredient (API) or Noscapin finished formulations upon request. The Noscapin suppliers may include Noscapin API manufacturers, exporters, distributors and traders.
click here to find a list of Noscapin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Noscapin DMF (Drug Master File) is a document detailing the whole manufacturing process of Noscapin active pharmaceutical ingredient (API) in detail. Different forms of Noscapin DMFs exist exist since differing nations have different regulations, such as Noscapin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Noscapin DMF submitted to regulatory agencies in the US is known as a USDMF. Noscapin USDMF includes data on Noscapin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Noscapin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Noscapin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Noscapin Drug Master File in Japan (Noscapin JDMF) empowers Noscapin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Noscapin JDMF during the approval evaluation for pharmaceutical products. At the time of Noscapin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Noscapin suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Noscapin Drug Master File in Korea (Noscapin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Noscapin. The MFDS reviews the Noscapin KDMF as part of the drug registration process and uses the information provided in the Noscapin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Noscapin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Noscapin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Noscapin suppliers with KDMF on PharmaCompass.
A Noscapin CEP of the European Pharmacopoeia monograph is often referred to as a Noscapin Certificate of Suitability (COS). The purpose of a Noscapin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Noscapin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Noscapin to their clients by showing that a Noscapin CEP has been issued for it. The manufacturer submits a Noscapin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Noscapin CEP holder for the record. Additionally, the data presented in the Noscapin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Noscapin DMF.
A Noscapin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Noscapin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Noscapin suppliers with CEP (COS) on PharmaCompass.
A Noscapin written confirmation (Noscapin WC) is an official document issued by a regulatory agency to a Noscapin manufacturer, verifying that the manufacturing facility of a Noscapin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Noscapin APIs or Noscapin finished pharmaceutical products to another nation, regulatory agencies frequently require a Noscapin WC (written confirmation) as part of the regulatory process.
click here to find a list of Noscapin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Noscapin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Noscapin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Noscapin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Noscapin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Noscapin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Noscapin suppliers with NDC on PharmaCompass.
Noscapin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Noscapin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Noscapin GMP manufacturer or Noscapin GMP API supplier for your needs.
A Noscapin CoA (Certificate of Analysis) is a formal document that attests to Noscapin's compliance with Noscapin specifications and serves as a tool for batch-level quality control.
Noscapin CoA mostly includes findings from lab analyses of a specific batch. For each Noscapin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Noscapin may be tested according to a variety of international standards, such as European Pharmacopoeia (Noscapin EP), Noscapin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Noscapin USP).
